Loading company…
Cologne biotechnology company developing regenerative therapies for skin healing and tissue repair.
Founded in 2015 and based in Cologne, Germany, NeraCare GmbH develops therapeutic products for regenerative medicine, sold to hospitals, dermatology clinics and pharmaceutical companies mainly in Europe and North America. CEO Matthias Ackermann leads the company, which raised EUR 8 million in Series A funding in March 2020 from MIG Capital and BayBG. The company has completed one deal to date and has a current valuation of EUR 24.761 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in